Acute Hemorrhagic Stroke

2

Review clinical trials related to Acute Hemorrhagic Stroke. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

AI-Driven Early Warning System for Perioperative Risks in Acute Hemorrhagic Stroke

Acute hemorrhagic cerebrovascular disease is a life-threatening condition characterized by sudden onset, rapid progression, multiple complications, poor prognosis, and high mortality. It presents a significant public health burden. During surgical interventions, precise risk stratification and effective perioperative management are crucial to mitigating intraoperative and postoperative complications, optimizing disease diagnosis, guiding severity assessment, and refining anesthesia strategies. Continuous real-time evaluation and dynamic perioperative adjustments are essential to minimize the influence of institutional variability and individual clinician-dependent decision-making. By harnessing big data-driven, evidence-based medical approaches, clinicians can enhance diagnostic accuracy and therapeutic precision, addressing a critical challenge in reducing morbidity and mortality in this patient population. This study aims to develop a comprehensive multimodal perioperative database and leverage large language models (LLMs) for the efficient extraction of structured demographic and clinical data throughout the perioperative course. By integrating real-time hemodynamic monitoring parameters, the investigators seek to elucidate the relationship between perioperative hemodynamic patterns and the incidence of postoperative complications affecting major organ systems, including the brain, heart, kidneys, and lungs. The ultimate goal is to construct a multimodal fusion early-warning model capable of real-time, simultaneous prediction of multiple perioperative complications. This AI-driven platform will function as a risk stratification and alert system for organ-specific perioperative complications in patients with acute hemorrhagic cerebrovascular disease. By providing evidence-based insights for optimized perioperative management-encompassing early warning mechanisms, diagnostic support, and individualized therapeutic strategies-the system aims to improve clinical outcomes, reduce perioperative morbidity, and lower overall mortality.

Participants needed: 1,533
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: Beijing Tiantan HospitalUpdated: May 31, 2025Locations: 1Duration: 3 Months
Eligibility criteria

Patients aged 18 to 80 years. [+6]

Patients who decline to provide informed consent. [+1]

Status: Recruiting

Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed tomography perfusion, is of great important in understanding pathophysiological changes, evaluating prognosis and guiding interventions in these diseases.

Participants needed: 10,000
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Xiaolin Chen, MDUpdated: Apr 4, 2025Locations: 1Duration: 1 Year
Eligibility criteria

age ≥ 18, ≤ 85 years; [+1]

with a history of previous history of ischemic/hemorrhagic stroke; [+6]